Oliceridine Exhibits Improved Tolerability Compared to Morphine at Equianalgesic Conditions: Exploratory Analysis from Two Phase 3 Randomized Placebo and Active Controlled Trials-Reference-Cited by-同舟云学术

Oliceridine Exhibits Improved Tolerability Compared to Morphine at Equianalgesic Conditions: Exploratory Analysis from Two Phase 3 Randomized Placebo and Active Controlled Trials

Published:2021-08-05 Issue:2 Volume:10 Page:1343-1353
ISSN:2193-8237
Container-title:Pain and Therapy
language:en
Short-container-title:Pain Ther

Author:

Hammer Gregory B.,Khanna Ashish K.,Michalsky Cathy,Wase Linda,Demitrack Mark A.,Little Roderick,Fossler Michael J.,Ayad Sabry

Funder

Trevena Inc.

Publisher

Springer Science and Business Media LLC

Subject

Anesthesiology and Pain Medicine,Neurology (clinical)

Link

https://link.springer.com/content/pdf/10.1007/s40122-021-00299-0.pdf

Reference28 articles.

1. Gan TJ, Habib AS, Miller TE, White W, Apfelbaum JL. Incidence, patient satisfaction, and perceptions of post-surgical pain: results from a US national survey. Curr Med Res Opin. 2014;30:149–60.

2. Gan TJ. Poorly controlled postoperative pain: prevalence, consequences, and prevention. J Pain Res. 2017;10:2287–98.

3. Small C, Laycock H. Acute postoperative pain management. Br J Surg. 2020;107:e70–80.

4. Echeverria-Villalobos M, Stoicea N, Todeschini AB, et al. Enhanced Recovery After Surgery (ERAS): a perspective review of postoperative pain management under ERAS pathways and its role on opioid crisis in the United States. Clin J Pain. 2020;36:219–26.

5. Chakravarthy V, Yokoi H, Manlapaz MR, Krishnaney AA. Enhanced recovery in spine surgery and perioperative pain management. Neurosurg Clin N Am. 2000;31:81–91.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endogenous opiates and behavior: 2021;Peptides;2023-06

2. Efficacy and safety of oliceridine treatment in patients with postoperative pain: a systematic review and meta-analysis of randomized controlled trials;Expert Review of Clinical Pharmacology;2023-05-15

3. Bispecific sigma-1 receptor antagonism and mu-opioid receptor partial agonism: WLB-73502, an analgesic with improved efficacy and safety profile compared to strong opioids;Acta Pharmaceutica Sinica B;2023-01

4. Emerging therapies in the management of Irritable Bowel Syndrome (IBS);Expert Opinion on Emerging Drugs;2022-01-02

5. Opioid Analgesia and Opioid-Induced Adverse Effects: A Review;Pharmaceuticals;2021-10-27